港股異動 | 李寧升4% 大店策略成效初顯營收增14.3%
格隆匯3月21日丨李寧(2331.HK)升4%,報58港元,1527億港元。李寧公佈2022年業績,公司營收繼2021年首破200億元以後再創新高達258.03億元,淨利潤為40.64億元,同比上升1.32%。對比來看,李寧2022年營收、淨利潤相較於2019年均實現翻倍增長。值得一提的是,與其他企業“關店潮”相反,李寧2022年線下店鋪逆勢增長,三年來首次實現門店數量大幅淨增。截至2022年12月31日,其銷售點數量(不包括李寧YOUNG)共計6295個,較2021年淨增360個。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.